Health Archive » April, 2008

Health - April, 2008

186 articles

• Warner Chilcott Settles Securities Case For $16.5M
• Ex-HealthSouth CFO Lawyers Ordered To Show Docs
• Judge Junks Applied's Appeal Of Covidien Verdict
• Texas Looks Again At Preemption Of Tort Lawsuits
• USPTO Will Confirm Key Lipitor Patent: Pfizer
• Philly Corpse Harvesters Face Lawsuit From Families
• Baycol Whistleblower Suit Unsealed In N.J. Court
• Nursing Home Can't Sue J&J For Pricing: 9th Circ.
• Tyco To Pay N.J. $73M To Settle Securities Suit
• 'Cutter' Convicted Of Stealing Human Tissue
• Baxter Sues Fresenius Again Over Dialysis Machine
• FDA Panel Says LASIK Merits Stronger Warnings
• Lawmakers Push FDA To Detail Needed Reforms
• Laserscope Shareholders Settle Insider Trading Claims
• Widow's $11M Medtronic Claims Time-Barred: Court
• FTC's Antitrust Suit Against Cephalon Moved To Pa.
• Taro Reaches Settlement With Shareholders
• Actavis Recalls Drug Over Possibly Deadly Defect
• FDA Passes New Rule On Foreign Drug Trials
• Quest Diagnostics To Give Workers Back Wages
• U.S., Abbott Spar Over Documents In AWP Case
• USPTO Refuses Again To Reissue Lipitor Patent
• Spectranetics, Medtronic Drop Catheter Patent Suit
• FTC Issues Final Order After Chicago Hospital Merger
• Unigen Hits Perrigo With Supplements Patent Suit
• Medtronic Unit Reaches Deal With FDA
• NuvaRing Plaintiffs Lobby For MDL
• FDA Proposes Funding Plans For Animal-Drug Reviews
• Genetic Bias Bill Sails Through Senate
• Bayer Faces 78 Trasylol Suits, CEO Says
• Frommer Can Defend Par In Rythmol Suit: Judge
• Eli Lilly's 'Restless Leg' Drug Permax Hits The Skids
• Bristol-Myers, Watson Settle Pravastatin Suit
• Bryan Cave Welcomes IP Partner
• Judge Keeps Device Suit V. Boston Scientific Alive
• Lonza, Northwest End Genetics Patent Wrangle
• FDA Official Tells Senators Agency Can't Keep Up
• Genentech Must Pay $300M In Royalties Case: Court
• Genetic Anti-Bias Bill Rouses Litigation Fears
• Humana Faces ERISA Suit Over Pension Plan Losses
• OIG Offers Carrot For Self-Disclosure Protocol
• Zyprexa Attorneys Come Up Short in Fee Request
• N.J. Jury Awards $10.5M In Third Accutane Trial
• DOJ Indicts Ex-Bristol-Myers Exec For Plavix Deal
• Biovail Settles Canadian Cardizem Suit
• 11th Circ. Tosses Sentence of HealthSouth Controller
• Insurer Had No Duty To Defend Corus: Judge
• Maltose Falsely Elevated Diabetics' Readings: FDA
• Does Riegel V. Medtronic Affect You?
• Suit Alleges WellPoint Defrauded Stockholders
• Doctors To Speak For Both Sides In Fen-Phen Trial
• Synthes Suffers One-Two Punch In Prodisc Suit
• Del. Courts Best For Tort, Contract Litigation: Study
• GAO Slams FDA Inspection Process
• FDA Finds New Data Linking Bad Heparin To China
• FDA Warns Philips After Plant Inspections
• FTC Puts Heat On Executives Amid AndroGel Probe
• UCB Sues KV Pharmaceutical Over Generic Metadate
• FDA Says Its Foreign Inspections Need A Face-Lift
• Pfizer's Viagra Video Spurs FDA Reprimand
• Medical Device Ruling Will Have Broad Impact
• Meda, Apotex Come To Terms In Astelin, Optivar Suits
• Bayer Takes On 2 More Generics Makers Over Yasmin
• Ala. Court OKs Joint Trials In Drug Pricing Suit
• J&J Unit Sues Over Monistat ANDA
• Parkinson's And Pesticide Link Grows Stronger
• Given Inks $2M Preliminary Settlement With Olympus
• High Court Declines To Hear Final Nucleonics Appeal
• Solicitor General Asked To Weigh In On Patent Case
• Insurance Cos. Sue For Piece Of Vioxx Settlement
• House Democrats Propose Drug Import Reforms
• Zyprexa Master Subpoenaed For Seroquel Case
• Judge Nixes Ortho-McNeil's Ultracet Patent
• DLA Piper Wins Over Four Heller Ehrman Partners
• FDA Reaffirms Bioequivalence Of Wellbutrin Generic
• First Circ. Revives Boston Scientific Securities Suit
• USPTO Continues VNUS Patent In Laser Treatment Suit
• Pfizer, Plaintiffs Spar Over Evidence
• Loeb & Loeb Nabs Drug Patent Lawyer From Gibbons
• Alcon Faces Antitrust Suit Over Eye Surgery Products
• Canadian Court Upholds Pfizer's Norvasc Patent
• Court Zaps Impax Suit Against Medicis Over Zit Drug
• SEC Files Suit Against Medical Device Company
• OraSure Faces Suit Over HIV Test, Says Patent Invalid
• Key Pharma Preemption Ruling In 3rd Circuit
• Workers Are Wary As Employers Go On Health Kick
• Debate Brews Over Tolling Rule In Mass Tort Cases
• Vioxx ERISA Plaintiffs Seek To Add Vytorin To Mix
• FDA Drug Tracking Unlikely To Improve: Attorneys
• Judge Tosses Suit In ABL-SmartGene Patent Spat
• FDA Suspects Fraud Led To Heparin Contamination
• UCB Sues Synthon Over ANDA For Xyzal
• McDermott Becomes Target Of St. Vincent's Ire
• Agis Can't Shed Patent Suit Over Scalp Treatment
• Federal Courts See Huge Rise In Class Actions
• Federal Circuit Deals Blow To Alpha Scientific
• Shareholders Seek To Block Millennium Takeover
• Cos. Spar Over PTO Re-Exam Of Stem Cell Patents
• Federal Circuit Affirms Pepcid Patent's Invalidity
• MediCor's Unsecured Creditors Object To Sale
• Merck Knew About Vioxx Dangers For Years: Report
• AstraZeneca, Ranbaxy Settle Nexium Patent Dispute
• WellPoint Hoping To Catch Drug Side Effects Sooner
• The Physician On-Call Dilemma: Emerging Solutions
• Innogenetics, Abbott Strike $9.5M Deal On HCV Patent
• Committee Answers Medtronic Plaintiffs' Objections
• Insurers Off The Hook In BASF Synthroid Spat
• Government Asks For More Time In AWP Case
• Court Will Not Award Fees To Roxane In Patent Spat
• Vytorin Saga Brings Another Suit For Schering-Plough
• Lundbeck Wins Appellate Ruling On Cipralex Patent
• FDA Watch Over Natural Supplements Growing Keener
• FDA Probes Roche, Novartis Drugs' Link To Disorder
• Bextra Plaintiffs Blast Summary Judgment Motion
• Genzyme Recalls Murky Batches Of Transplant Drug
• FDA Weighs Options After Teva Wins Risperdal Spat
• EPA Holds Off On Regulating Drugs In Water Supply
• HGS, Immunex Discovery May Go Beyond USPTO
• Canadian Class Certified Over Guidant Medical Devices
• Halted Cancer Drug Trials May Harm Patients: Study
• Luma Loses Appeal Of Endoscopy Patent Case
• Roche Appeals Preliminary Injunction Barring Mircera
• Rx.com Revives Battle With Pharmacy Managers
• MDL Panel Opts To Centralize Vytorin Litigation
• Health Canada To Investigate Relenza
• Cubist Finds Contaminant In Popular Antibiotic
• Biovail Founder Drops Canadian Proxy Suit
• 11th Circuit Vacates Injunctions Against Axiom
• FDA Links More Deaths To Heparin
• Vascular, Diomed Settle Vein Treatment Patent Suit
• Lung Cancers Prompt Pfizer To Revise Exubera Label
• Court Backs Drug Cos. In Suicide Cases
• Icahn Tries To Bully Biogen
• FDA Censures Glaxo Over Flawed Avandia Reports
• Boston Scientific Snags Medical Device Bigwig
• KV Pharmaceuticals Settles Derivative Suit
• Judge Issues Injunction On Medicare Bidding Project
• FDA Precludes Expert Testimony On Ortho-Evra: J&J
• 8th Circ. Decertifies Class In St. Jude Valve Case
• Louisiana AG Yanks Amgen Antitrust Case
• Orthopedic Surgeons Should Prepare For Scrutiny
• CORRECTION: $23M Verdict In LifeNet Case Upheld
• Sanofi, Abbott Sue Glenmark Over Hypertension Drug
• Bristol-Myers Strikes $5M Deal For Orencia
• J&J, Ortho-Evra Plaintiffs Duel Over Experts
• Judge Grants $430M In Fen-Phen Attorneys' Fees
• P&G Files A Third Suit To Stop Generic Actonel
• Teva Unit Enters $10M Settlement With Depomed
• Zimmer Recalls Surgical Products After Inspection
• BD Wins Ruling Over Two Abbott Glucose Strip Patents
• Dewey & LeBoeuf To Shutter Three Offices
• Dialysis Machine Sales Halted Over Patent Dispute
• Humana Hit With Shareholder Class Action
• Baxter Plan Participants Can Sue Under ERISA: Court
• Judge Denies Applera, Illumina Bids For Judgment
• Amicus Briefs Fuel Debate In Business Method Case
• Vytorin Headache Grows With Shareholder Suit
• Wellbutrin Drug Cos. Were Anti-Competitive: Suit
• Objections Force FDA To Withdraw New Rules
• Exclusivity Parking Still Possible Under Teva Ruling
• Supreme Court Lets Takeda's Actos Patent Stand
• Financial Pains Pushing Hospitals To Bankruptcy
• Judge OKs $11M Deal In Brain Aneurysm Patent Suit
• Viagra Judge Strikes Expert's Testimony
• Novartis Makes Drug Available Only In Dire Situations
• Here Comes The Tidal Wave Of Generic DJ Actions
• Chase Medical Comes Up Short In Treble Damages Bid
• Judge Rules Merge Tech Fraud Suit Can Move Forward
• Judge Sides With Novartis In Aredia, Zometa MDL
• Merck Seeks To Quash Ranbaxy's Subpoenas
• Acting Attorney General Goes Home To Sidley
• Celebrex Linked To Increased Heart Attack Risk
• DOJ Joins In Kickback Suit Against Ohio Hospital
• Judge Quashes Immediate Appeal In Hormone Case
• Sandoz Faces Another Suit Over Generic Clarinex
• Teva Sued For Seeking Approval For Generic Abilify
• Respironics Wins Judgment in Antitrust Case
• New Patent Injected Into Becton's Syringe Feud
• J&J, Amgen Scrutinized For Anemia Drug Marketing
• St. Jude Knowingly Marketed Faulty Leads: Suit
• Terumo Hit With Patent Suits In ITC And U.S. Court
• Teva To Appeal Decision Blocking Generic Prevacid
• Judge Invalidates New USPTO Rules
• Federal Circuit Revives Lexapro Patent Suit
• GSK Violated Competition Laws: EU Advocate General
• Novartis Plays Down Impact Of Split High Court Ruling